 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
8-18-2022
Insider Buy |
Michael J. Tattersfield
President and CEO |
$12.61
CAGR »
|
$378,225.00
30,000 shares |
3-11-2022
Insider Buy |
Michael J. Tattersfield
President and CEO |
$13.90
CAGR »
|
$271,025.00
19,500 shares |
12-1-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$13.46
CAGR »
|
$4,037,758.50
300,000 shares |
11-30-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.28
CAGR »
|
$3,921,885.62
274,683 shares |
11-29-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$15.41
CAGR »
|
$3,466,237.50
225,000 shares |
11-26-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$15.27
CAGR »
|
$4,029,698.25
263,950 shares |
11-24-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.87
CAGR »
|
$2,825,635.58
190,000 shares |
11-23-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.47
CAGR »
|
$3,817,682.96
263,900 shares |
11-22-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.12
CAGR »
|
$3,725,370.74
263,900 shares |
11-19-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$13.83
CAGR »
|
$3,097,866.03
223,988 shares |
11-18-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.16
CAGR »
|
$3,422,716.92
241,700 shares |
11-17-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.79
CAGR »
|
$3,533,580.94
238,841 shares |
11-16-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.65
CAGR »
|
$3,540,518.28
241,700 shares |
11-15-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.44
CAGR »
|
$3,360,290.41
232,749 shares |
11-12-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.56
CAGR »
|
$2,591,074.80
178,000 shares |
11-11-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$14.25
CAGR »
|
$1,254,105.60
88,000 shares |
11-11-2021
Insider Buy |
Olivier Goudet
Director |
$13.86
CAGR »
|
$693,235.00
50,000 shares |
11-11-2021
Insider Buy |
Michael J. Tattersfield
President and CEO |
$13.86
CAGR »
|
$554,372.00
40,000 shares |
9-10-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$15.97
CAGR »
|
$9,310,754.09
582,973 shares |
9-3-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$16.38
CAGR »
|
$7,646,254.10
466,713 shares |
9-8-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$15.25
CAGR »
|
$10,668,624.71
699,642 shares |
8-31-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$16.66
CAGR »
|
$474,914.33
28,509 shares |
8-30-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$16.97
CAGR »
|
$2,959,422.65
174,435 shares |
8-24-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$16.66
CAGR »
|
$11,886,292.07
713,360 shares |
8-26-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$16.97
CAGR »
|
$7,448,410.90
438,810 shares |
8-19-2021
Insider Buy |
Michael J. Tattersfield
President and CEO |
$14.30
CAGR »
|
$150,148.60
10,500 shares |
8-19-2021
Insider Buy |
Olivier Goudet
Director |
$13.21
CAGR »
|
$792,660.00
60,000 shares |
8-20-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$15.19
CAGR »
|
$4,475,895.75
294,748 shares |
8-19-2021
Insider Buy |
Holdings B.V. Jab
>10% Owner |
$14.39
CAGR »
|
$3,378,075.04
234,748 shares |
7-6-2021
Insider Buy |
Patricia Capel
Director |
$17.00
CAGR »
|
$78,540.00
4,620 shares |
7-6-2021
Insider Buy |
Debbie Sharell Roberts
Director |
$17.00
CAGR »
|
$84,150.00
4,950 shares |
7-6-2021
Insider Buy |
Michael J. Tattersfield
President and CEO |
$17.00
CAGR »
|
$10,030.00
590 shares |
7-6-2021
Insider Buy |
Indulgence B.V. Jab
>10% Owner |
$16.02
CAGR »
|
$94,250,000.94
5,882,353 shares |
7-6-2021
Insider Buy |
Olivier Goudet
Director |
$16.02
CAGR »
|
$4,712,505.66
294,118 shares |
Also See: Institutional Holders of DNUT
Also See: SEC filings
Below we present the annualized performance delivered by DNUT stock since 8-18-2022 (the date of the most recent
insider purchase). The performance of the investment from the time DNUT insider buying occurred is the ultimate
test of whether insiders were right about DNUT being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
08/19/2022 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$12.19 |
|
| End price/share: |
$13.40 |
|
| Starting shares: |
820.34 |
|
| Ending shares: |
832.93 |
|
| Dividends reinvested/share: |
$0.21 |
|
| Total return: |
11.61% |
|
| Average Annual Total Return: |
6.77% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,160.95 |
|
| Years: |
1.68 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/19/2022 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$12.19 |
|
| End price/share: |
$13.40 |
|
| Dividends collected/share: |
$0.21 |
|
| Total return: |
11.65% |
|
| Average Annual Total Return: |
6.79% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,164.46 |
|
| Years: |
1.68 |
|
DNUT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent DNUT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding DNUT
|
|
Free DNUT Email Alerts:
